Business Segments · Research and development expense
Connected Care — Research and development expense
Becton, Dickinson and Company Connected Care — Research and development expense increased by 5.9% to $90M in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ2 2026May 7, 2026
Rolls up toR&D
How to read this metric
Higher spending typically signals a commitment to long-term growth and pipeline development, while lower spending may indicate a focus on short-term profitability.
Detailed definition
This metric tracks the investment in research and development activities specifically dedicated to the Connected Care se...
Peer comparison
Standard R&D investment metric for medical technology companies focused on innovation.
Metric ID:
bdx_segment_connected_care_research_and_development_expenseHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|
| Value | $80M | $74M | $85M | $90M |
| QoQ Change | — | -7.5% | +14.9% | +5.9% |
| YoY Change | — | — | +6.3% | +21.6% |
Range$74M – $90M
Avg YoY Growth+13.9%
Median YoY Growth+13.9%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's connected care — research and development expense?
- Becton, Dickinson and Company (BDX) reported connected care — research and development expense of $90M in Q1 2026.
- What does connected care — research and development expense mean?
- Total spending on innovation and product development for the Connected Care segment.